Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Thrombotic thrombocytopenic purpura. A case report & review of the literature.

Abdallah MP, Nehme ME, Azar CG.

J Med Liban. 1999 May-Jun;47(3):205-7.

PMID:
10550949
3.

Expression of TrkA, TrkB and TrkC in human neuroblastomas.

Brodeur GM, Nakagawara A, Yamashiro DJ, Ikegaki N, Liu XG, Azar CG, Lee CP, Evans AE.

J Neurooncol. 1997 Jan;31(1-2):49-55.

PMID:
9049830
4.

Expression and function of TRK-B and BDNF in human neuroblastomas.

Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM.

Mol Cell Biol. 1994 Jan;14(1):759-67.

5.

Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.

Azar CG, Scavarda NJ, Nakagawara A, Brodeur GM.

Prog Clin Biol Res. 1994;385:169-75.

PMID:
7972209
6.

Clinical significance of expression of neurotrophic factors and their receptors in neuroblastoma.

Nakagawara A, Arima-Nakagawara M, Azar CG, Scavarda NJ, Brodeur GM.

Prog Clin Biol Res. 1994;385:155-61. No abstract available.

PMID:
7972207
7.

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.

Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM.

N Engl J Med. 1993 Mar 25;328(12):847-54.

8.

Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.

Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM.

Cancer Res. 1992 Mar 1;52(5):1364-8.

9.

Multiple defects of the nerve growth factor receptor in human neuroblastomas.

Azar CG, Scavarda NJ, Reynolds CP, Brodeur GM.

Cell Growth Differ. 1990 Sep;1(9):421-8.

10.

Phenoxybenzamine in the treatment of causalgia. Report of 40 cases.

Ghostine SY, Comair YG, Turner DM, Kassell NF, Azar CG.

J Neurosurg. 1984 Jun;60(6):1263-8.

PMID:
6726371

Supplemental Content

Support Center